EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Pharmacovigilance challenges of COVID-19 vaccine safety monitoring during the pandemic - a narrative review

Dagmara Mirowska-Guzel, Magdalena Niedzielko, Barbara De Bernardi, Antonella Fretta, Marcin Kruk, Weronika Lepionka, Kavita Ramji, Patrick Caubel

Prospects in Pharmaceutical Sciences · 2026-06-15 · 24 (2) · 149-160

DOI: 10.56782/pps.739 ↗

At a glance

Journal article in Prospects in Pharmaceutical Sciences, published online on 2026-06-15. Written by Dagmara Mirowska-Guzel and 7 co-authors. 79 references. The full text is freely available (open access, CC BY 4.0).

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

This article explores the challenges related to the immense workload associated with pharmacovigilance during the COVID-19 pandemic as well as strategies and solutions employed by key stakeholders, including regulators, industry, and academia. The rapid development and rollout of COVID-19 vaccines was accompanied by increased public interest in their safety, resulting in the collection and analysis of an unprecedented volume of safety data. Requests from regulators worldwide for the accelerated preparation and submission of aggregate safety reports, as well as ad hoc data requests, presented additional challenges. The academic community voluntarily contributed by summarizing emerging evidence on vaccine safety, conducting research to clarify potential mechanisms underlying adverse events, and examining factors associated with vaccine hesitancy. An effective pharmacovigilance system played a crucial role in gathering and rapidly analyzing large amounts of data to identify signals, refine the safety profile of a new medicinal product, and respond promptly to any emerging concerns to ensure that patients are not exposed to medications with an unfavourable benefit–risk balance.

Cite

APA

Mirowska-Guzel, D., Niedzielko, M., Bernardi, B. D., Fretta, A., Kruk, M., Lepionka, W., Ramji, K., & Caubel, P. (2026). Pharmacovigilance challenges of COVID-19 vaccine safety monitoring during the pandemic - a narrative review. Prospects in Pharmaceutical Sciences, 24(2), 149-160. https://doi.org/10.56782/pps.739

Vancouver

Mirowska-Guzel D, Niedzielko M, Bernardi BD, Fretta A, Kruk M, Lepionka W, et al. Pharmacovigilance challenges of COVID-19 vaccine safety monitoring during the pandemic - a narrative review. Prospects in Pharmaceutical Sciences. 2026;24(2):149-160. doi:10.56782/pps.739

BibTeX
@article{MirowskaGuzel2026,
  author = {Mirowska-Guzel, Dagmara and Niedzielko, Magdalena and Bernardi, Barbara De and Fretta, Antonella and Kruk, Marcin and Lepionka, Weronika and Ramji, Kavita and Caubel, Patrick},
  title = {Pharmacovigilance challenges of COVID-19 vaccine safety monitoring during the pandemic - a narrative review},
  journal = {Prospects in Pharmaceutical Sciences},
  year = {2026},
  volume = {24},
  number = {2},
  pages = {149--160},
  doi = {10.56782/pps.739}
}
Start for free →